Anton Porsteinsson, MD

By  the year 2050, it is estimated that the number of people with Alzheimer disease  and other forms of dementia will explode to 36 million in the US and over 160  million worldwide, over 3 times the current rate. Once a patient has dementia,  efforts to reverse it are challenging. Research in the last 10 years has  focused on our ability to identify preclinical stages and has moved forward  rapidly.

Here to provide a preview of his presentation at the 

US  Psychiatric and Mental Health Congress

 in San Diego is Dr Anton P.  Porsteinsson, William B. and Sheila Konar Professor and Director of the  Alzheimer Disease Care Research and Education Program at the University of  Rochester School of Medicine and Dentistry in Rochester, NY.

His presentation, “Preventing Cognitive Decline in Your Patients” is scheduled for  Thursday, November 8th, from 4 to 5:30 PM.

Podcasts

By the year 2050, it is estimated that the number of people with Alzheimer disease and other forms of dementia will explode to 36 million in the US and over 160 million worldwide, over 3 times the current rate.

Preventing the Onset of Cognitive Decline

Anton Porsteinsson, MD, discusses some specifics for fine-tuning the care of patients with Alzheimer disease. Here: optimizing physical health and mental stimulation and promoting a brain healthy diet and aerobic exercise.

Articles

 Anton Porsteinsson, MD, discusses some specifics for fine-tuning the care of patients with Alzheimer disease. Here: optimizing physical health and mental stimulation and promoting a brain-healthy diet and aerobic exercise.

Video: Delaying Symptom Deterioration in Alzheimer Dementia

Can stimulants increase function in people with early stage Alzheimer disease? Here, Anton Porsteinsson, MD, discusses the pros and cons.

Can stimulants increase function in people with early stage Alzheimer disease? Here, Anton Porsteinsson, MD, discusses the pros and cons.

Video: Stimulants in Alzheimer Dementia: What Role in Early Disease?

In this video, Anton Porsteinsson, MD, discusses some of the causative factors of Alzheimer disease: genetics, environment, personality. He goes on to explain that although there are clear determinants for AD, there are preventive actions that can be taken to delay the onset of disability.

 In this video, Anton Porsteinsson, MD, discusses some of the causative factors of Alzheimer disease: genetics, environment, personality. He goes on to explain that although there are clear determinants for AD, there are preventive actions that can be taken to delay the onset of disability.

Author | Anton Porsteinsson, MD

Articles

New content coming soon, please check back later.